Zibotentan
Zibotentan (pronounced as zee-boh-ten-tan) is a type of medication specifically designed as an endothelin receptor antagonist. It is primarily used in the treatment of prostate cancer.
Etymology
The term "Zibotentan" is a coined name, like many pharmaceutical drugs, and does not have a specific etymology.
Usage
Zibotentan is used in the treatment of hormone-resistant prostate cancer. It works by blocking the action of a natural substance called endothelin-1 which is often found in high levels in men with prostate cancer. By blocking the action of endothelin-1, Zibotentan can slow the growth of the cancer and may also prevent the growth of new blood vessels within the cancer.
Related Terms
- Endothelin receptor antagonist: A type of medication that blocks the action of endothelin-1.
- Prostate cancer: A type of cancer that occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.
- Hormone-resistant prostate cancer: A type of prostate cancer that is not responding to the hormone therapy.
- Endothelin-1: A protein that constricts blood vessels and raises blood pressure. It is often found in high levels in men with prostate cancer.
See Also
External links
- Medical encyclopedia article on Zibotentan
- Wikipedia's article - Zibotentan
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski